Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
Clinical trial NCT04328727 · COMPLETED
Trial details
- NCT number
- NCT04328727
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2022-06-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.